The genetics of severe depression.

Area of Science:

• Psychiatric Genetics
• Molecular Psychiatry
• Genomics

Background:

• Genome-wide association studies (GWAS) for major depressive disorder (MDD) have identified numerous loci, but some may be associated with dysphoria, limiting clinical relevance.
• Focusing GWAS on severe MDD forms (e.g., early onset, recurrence, functional impairment, ECT treatment) may enrich for larger effect loci, yielding more clinically actionable findings.

Purpose of the Study:

• To review the genetic underpinnings of severe MDD by examining clinical markers of illness severity.
• To evaluate the potential of severe MDD phenotypes to yield more clinically relevant genetic discoveries.

Main Methods:

• Review of existing literature on the genetics of severe depression.
• Analysis of clinical markers of severity: age of onset, recurrence, functional impairment, and electroconvulsive therapy (ECT) treatment.
• Examination of findings from GWAS and whole exome sequencing studies in severe MDD populations.

Main Results:

• Evidence suggests increased heritability for recurrent, early-onset, and functionally impairing MDD.
• GWAS and whole exome sequencing studies have identified potential genome-wide loci and rare variants associated with severe MDD, though replication is pending.
• Elevated heritability in severe MDD phenotypes supports further genome-wide investigation.

Conclusions:

• Severe MDD phenotypes show promise for identifying clinically actionable genetic loci.
• Future research requires large cohorts with consistent phenotyping for robust genetic discoveries in severe MDD.
• The Gen-ECT-ics consortium is actively pursuing this strategy with a 50-site global collaboration.